Current Heart Failure Reports

, Volume 10, Issue 4, pp 341–349 | Cite as

Ventricular Remodeling in Heart Failure with Preserved Ejection Fraction

Pathophysiology of Myocardial Failure (IS Anand and M Sarraf, Section Editors)


Heart failure with preserved ejection fraction (HFpEF) is common, increasing in prevalence, and causes substantial morbidity and mortality. HFpEF has commonly been viewed as an expression of advanced hypertensive heart disease, with a cardiac phenotype characterized by an increase in wall thickness-to-chamber radius ratio (concentric hypertrophy). However, marked clinical heterogeneity within this syndrome is now well appreciated, and is mirrored in the variability in left ventricular (LV) structure. A review of larger imaging studies from epidemiology and clinical trial cohorts demonstrate that while concentric LV remodeling is common, it is by no means universal and many patients demonstrate normal LV geometry or even an eccentric pattern. More detailed assessment of cardiac structure and function in broader HFpEF populations will be necessary to better define the prevalence, determinants, and prognostic relevance of these measures, which may in turn serve as a foundation to identify pathophysiologically relevant sub-phenotypes within this diverse syndrome.


Heart failure Preserved Ejection Fraction Ventricular Remodeling Echocardiography 


Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med. 2006;355:260–9.PubMedCrossRefGoogle Scholar
  2. 2.
    Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355:251–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Tsutsui H, Tsuchihashi M, Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol. 2001;88:530–3.PubMedCrossRefGoogle Scholar
  4. 4.
    Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol. 2003;41:1510–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Vasan RS, Larson MG, Benjamin EJ, Evans JC, Reiss CK, Levy D. Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol. 1999;33:1948–55.PubMedCrossRefGoogle Scholar
  6. 6.
    Davis BR, Kostis JB, Simpson LM, Black HR, Cushman WC, Einhorn PT, et al. Heart failure with preserved and reduced left ventricular ejection fraction in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Circulation. 2008;118:2259–67.PubMedCrossRefGoogle Scholar
  7. 7.
    Yusuf S, Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJV, et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet. 2003;362:777–81.PubMedCrossRefGoogle Scholar
  8. 8.
    Cleland JGF, Tendera M, Adamus J, Freemantle N, Polonski L, Taylor J, et al. The perindopril in elderly people with chronic heart failure (PEP-CHF) study. Eur Heart J. 2006;27:2338–45.PubMedCrossRefGoogle Scholar
  9. 9.
    Massie BM, Carson PE, McMurray JJ, Komajda M, McKelvie R, Zile MR, et al. Ptaszynska A for the I-PRESERVE investigators. N Engl J Med. 2008;359:2456–67.PubMedCrossRefGoogle Scholar
  10. 10.
    Aurigemma GP, Gaasch WH. Diastolic heart failure. N Engl J Med. 2004;351:1097–105.PubMedCrossRefGoogle Scholar
  11. 11.
    • Lam CSP, Donal E, Kraigher-Krainer E, Ramachandran VS. Epidemiology and clinical course of heart failure with preserved ejection fraction. Eur J Heart Fail. 2011;13:18–28. Comprehensive review of the clinical characteristics and outcomes in epidemiology, registry, and clinical trial cohorts of patients with HFpEF.PubMedCrossRefGoogle Scholar
  12. 12.
    Linzbach AJ. Heart failure from the point of view of quantitative anatomy. Am J Cardiol. 1960;5:370–82.PubMedCrossRefGoogle Scholar
  13. 13.
    Grossman W, Jones D, McLaurin LP. Wall stress and petterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56–64.PubMedCrossRefGoogle Scholar
  14. 14.
    Kitzman DW, Little WC, Brubaker PH, Anderson RT, Hundley WG, Marburger CT, et al. Pathophysiological characterization of isolated diastolic heart failure in comparison to systolic heart failure. JAMA. 2002;288:2144–50.PubMedCrossRefGoogle Scholar
  15. 15.
    Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH, et al. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction. J Am Coll Cardiol. 2007;49:198–207.PubMedCrossRefGoogle Scholar
  16. 16.
    Von Heerebeek L, Borbely A, Niessen HWM, Bronzwaer JGF, van der Velden J, Stienen GJM, et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation. 2006;113:1966–73.PubMedCrossRefGoogle Scholar
  17. 17.
    Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure – abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med. 2004;350:1953–9.PubMedCrossRefGoogle Scholar
  18. 18.
    Westermann D, Kasner M, Steendijk P, Spillman F, Riad A, Weitmann K, et al. Role of left ventricular stiffness in heart failure with normal ejection fraction. Circulation. 2008;117:2051–60.PubMedCrossRefGoogle Scholar
  19. 19.
    Ho JE, Gona P, Pencina MJ, Tu JV, Austin PC, Vasan RS, et al. Discriminating clinical feastures of heart failure with preserved versus reduced ejection fraction in the community. Eur Heart J. 2012;33:1734–41.PubMedCrossRefGoogle Scholar
  20. 20.
    Lam CS, Lyass A, Kraigher-Krainer E, Massaro JM, Lee DS, Ho JE, et al. Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community. Circulation. 2011;124:24–30.PubMedCrossRefGoogle Scholar
  21. 21.
    Shah SJ. Evolving approaches to the management of heart failure with preserved ejection fraction in patients with coronary artery disease. Curr Treat Options Cardiovasc Med. 2010;12:58–75.PubMedCrossRefGoogle Scholar
  22. 22.
    Abhayaratna WP, Marwick TH, Smith WT, Becker NG. Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey. Heart. 2006;92:1259–64.PubMedCrossRefGoogle Scholar
  23. 23.
    Persson H, Lonn E, Edner M, Baruch L, Lang CC, Morton JJ, et al. Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence: results from the CHARM Echocardiographic Substudy – CHARMES. J Am Coll Cardiol. 2007;49:687–94.PubMedCrossRefGoogle Scholar
  24. 24.
    • Zile MR, Gottdiener JS, Hetzel SJ, McMurray JJ, Komajda M, McKelvie R, et al. Prevalence and significance of alterations in cardiac structure and function in patients with heart failure and a preserved ejection fraction. Circulation. 2011;124:2491–501. The largest, most comprehensive dedicated echocardiographic study of patients with HFpEF which also related measures of cardiac structure and function to clinical outcomes in this population.PubMedCrossRefGoogle Scholar
  25. 25.
    Yip GW, Zhang Q, Xie JM, et al. Resting global and regional left ventricular contractility in patients with heart failure and normal ejection fraction: insights from speckle-tracking echocardiography. Heart. 2011;97:287–94.PubMedCrossRefGoogle Scholar
  26. 26.
    Tan YT, Wenzelburger F, Lee E, et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol. 2009;54:36–46.PubMedCrossRefGoogle Scholar
  27. 27.
    Yu CM, Zhang Q, Yip GWK, Lee PW, Kum LCC, Lam YY, et al. Diastolic and systolic asynchrony in patients with diastolic heart failure: a common but ignored condition. J Am Coll Cardiol. 2007;49:97–105.PubMedCrossRefGoogle Scholar
  28. 28.
    Wang J, Kurrelmeyer KM, Torre-Amione G, Nagueh SF. Systolic and diastolic dyssynchrony in patients with diastolic heart failure and the effect of medical therapy. J Am Coll Cardiol. 2007;49:88–96.PubMedCrossRefGoogle Scholar
  29. 29.
    Kurt M, Wang J, Torre-Amione G, Nagueh SF. Left atrial function in diastolic heart failure. Circ Cardiovasc Imaging. 2009;2:10–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Lam CSP, Roger VL, Rodeheffer RJ, Borlaug BA, Enders FT, Redfield MM. Pulmonary hypertension in heart failure with preserved ejection fraction: a community-based study. J Am Coll Cardiol. 2009;53:1119–26.PubMedCrossRefGoogle Scholar
  31. 31.
    Kawaguchi M, Hay I, Fetics B, Kass DA. Combined ventricular systolic and arterial stiffening in patients with heart failure and preserved ejection fraction: implications for systolic and diastolic reserve limitations. Circulation. 2003;107:714–20.PubMedCrossRefGoogle Scholar
  32. 32.
    Hykowsky MJ, Brubaker PH, John JM, Stewart KP, Morgan TM, Kitzman DW. Determinants of exercise intolerance in elderly heart failure patients with preserved ejection fraction. J Am Coll Cardiol. 2011;58:265–74.CrossRefGoogle Scholar
  33. 33.
    Shah AM, Pfeffer MA. The many faces of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2012;9:555–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Zile MR, Gaasch WH, Carroll JD, Feldman MD, Aurigemma GP, Schaer GL, et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure? Circulation. 2001;104:779–82.PubMedCrossRefGoogle Scholar
  35. 35.
    Leong DP, De Pasquale CG, Selvanayagam JB. Heart failure with normal ejection fraction: the complementary roles of echocardiography and CMR imaging. J Am Coll Cardiol Img. 2010;3:409–20.CrossRefGoogle Scholar
  36. 36.
    Douglas PS, DeCara JM, Devereux RB, Duckworth S, Gardin JM, Jaber WA, et al. Echocardiographic imaging in clinical trials: American Society of Echocardiography standards for echocardiography core laboratories: endorsed by the American College of Cardiology Foundation. J Am Soc Echocardiogr. 2009;22:755–65.PubMedCrossRefGoogle Scholar
  37. 37.
    Edelmann F, Wachter R, Schmidt AG, Kraigher-Krainer E, Colantonio C, Kamke W, et al. Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the ALDO-DHF randomized controlled trial. JAMA. 2013;209:781–91.CrossRefGoogle Scholar
  38. 38.
    Lam CSP, Roger VL, Rodeheffer RJ, Bursi F, Borlaug BA, Ommen SR, et al. Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted County, Minnesota. Circulation. 2007;115:1982–90.PubMedCrossRefGoogle Scholar
  39. 39.
    Maurer MS, Burkhoff D, Fried LP, Gottdiener J, King DL, Kitzman DW. Ventricular structure and function in hypertensive participants with heart failure and a normal ejection fraction: the Cardiovascular Health Study. J Am Coll Cardiol. 2007;49:972–81.PubMedCrossRefGoogle Scholar
  40. 40.
    • Katz DH, Beussink L, Sauer AJ, Freed BH, Burke MA, Shah SJ. Prevalence, clinical characteristics, and outcomes associated with eccentric versus concentric left ventricular hypertrophy in heart failure with preserved ejection fraction. Am J Cardiol. 2013. doi:10.1016/j.amjcard.2013.05.061. Large, comprehensive echocardiographic study of a registry-based HFpEF cohort which evaluated the prognostic relevance of differences in ventricular geometry on clinical outcomes.
  41. 41.
    Solomon SD, Zile M, Pieske B, Voors A, Shah A, Kraigher-Krainer E, et al. The angiotensin receptor neprilysin inhibitor LCZ696 in heart failure with preserved ejection fraction: a phase II randomized-controlled trial. Lancet. 2012;380:1387–95.PubMedCrossRefGoogle Scholar
  42. 42.
    Devereux RB, Roman MJ, Liu JE, Welty TK, Lee E, Rodeheffer R, et al. Congestive heart failure despite normal left ventricular systolic function in a population-based sample: the Strong Heart Study. Am J Cardiol. 2000;86:1090–6.PubMedCrossRefGoogle Scholar
  43. 43.
    He KL, Burkhoff D, Leng WX, Liang ZR, Fan L, Wang J, et al. Comparison of ventricular structure and function in Chinese patients with heart failure and ejection fractions >55% versus 40% to 55% versus <40%. Am J Cardiol. 2009;103:845–51.PubMedCrossRefGoogle Scholar
  44. 44.
    Santhanakrishnan R, Ng TP, Cameron VA, Gamble GD, Ling LH, Sim D, et al. The Singapore Heart Failure Outcomes and Phenotypes (SHOP) study and Prospective Evaluation of Outcomes in Patients with Heart Failure with Preserved Left Ventricular Ejection Fraction (PEOPLE) study: rationale and design. J Card Fail. 2013;19:156–62.PubMedCrossRefGoogle Scholar
  45. 45.
    Yancy CW. Heart failure in African Americans: pathophysiology and treatment. J Card Fail. 2003;9:s210–5.PubMedCrossRefGoogle Scholar
  46. 46.
    Bahrami H, Kronmal R, Bluemke DA, Olson J, Shea S, Liu K, et al. Difference in the incidence of congestive heart failure by ethnicity: the Multi-Ethnic Study of Atherosclerosis. Arch Intern Med. 2008;168:2138–45.PubMedCrossRefGoogle Scholar
  47. 47.
    East MA, Peterson ED, Shaw LK, Gattis WA, O’Connor CM. Racial differences in the outcomes of patients with diastolic heart failure. Am Heart J. 2004;148:151–6.PubMedCrossRefGoogle Scholar
  48. 48.
    Lorber R, Gidding SS, Daviglus ML, Colangelo LA, Liu K, Gardin JM. Influence of systolic blood pressure and body mass index on left ventricular structure in healthy African-American and white young adults: the CARDIA study. J Am Coll Cardiol. 2003;41:955–60.PubMedCrossRefGoogle Scholar
  49. 49.
    Sharp A, Tapp R, Francis DP, Thom SAM, Hughes AD, Stanton AV, et al. J Am Coll Cardiol. 2008;52:1015–21.PubMedCrossRefGoogle Scholar
  50. 50.
    Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, Province MA, et al. Devereux. Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension. 2004;43:1182–8.PubMedCrossRefGoogle Scholar
  51. 51.
    Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, Kazi F, et al. Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension. 2005;46:124–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Gupta DK, Shah AM, Castagno D, Takeuchi M, Loehr LR, Fox ER, et al. Heart failure with preserved ejection fraction in African Americans: the ARIC (Atherosclerosis Risk in Communities) study. J Am Coll Cardiol Heart Fail. 2013;1:156–63.Google Scholar
  53. 53.
    Lester SJ, Tajik AJ, Nishimura RA, Oh JK, Khandheria BK, Seward JB. Unlocking the mysteries of diastolic function: deciphering the Rosetta stone 10 years later. J Am Coll Cardiol. 2008;51:679–89.PubMedCrossRefGoogle Scholar
  54. 54.
    Fouad FM, Slominiski JM, Tarazi RC. Left ventricular diastolic function in hypertension: relation to left ventricular mass and systolic function. J Am Coll Cardiol. 1984;3:1500–6.PubMedCrossRefGoogle Scholar
  55. 55.
    Aurigemma GP, Silver KH, Priest MA, Gaasch WH. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195–202.PubMedCrossRefGoogle Scholar
  56. 56.
    Aurigemma GP, Gaasch WH, McLaughlin M, McGinn R, Sweeney A, Meyer TE. Reduced left ventricular systolic pump performance and depressed myocardial contractile function in patients ≥65 years of age with normal ejection fraction and a high relative wall thickness. Am J Cardiol. 1995;76:702–5.PubMedCrossRefGoogle Scholar
  57. 57.
    Palmieri V, Wachtell K, Gerdts E, Bella JN, Papademetriou V, Tuxen C, et al. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. Am Heart J. 2001;141:784–91.PubMedCrossRefGoogle Scholar
  58. 58.
    Kuznetsova T, Herbots L, Richart T, D’hooge J, Thijs L, Fagard RH, et al. Left ventricular strain and strain rate in a general population. Eur Heart J. 2008;29:2014–23.PubMedCrossRefGoogle Scholar
  59. 59.
    Mizuguchi Y, Oishi Y, Miyoshi H, Iuchi A, Nagase N, Oki T. The functional role of longitudinal, circumferential, and radial myocardial deformation for regulating the early impairment of left ventricular contraction and relaxation in patients with cardiovascular risk factors: a study with two-dimensional strain imaging. J Am Soc Echocardiogr. 2008;21:1138–44.PubMedCrossRefGoogle Scholar
  60. 60.
    Fang ZY, Leano R, Marwick TH. Relationship between longitudinal and radial contractility in subclinical diabetic heart disease. Clin Sci (Lond). 2004;106:53–60.CrossRefGoogle Scholar
  61. 61.
    Carasso S, Cohen O, Mutlak D, Adler Z, Lessick J, Reisner SA. Differential effects of afterload on left ventricular long- and short-axis function: insights from a clinical model of patients with aortic valve stenosis undergoing aortic valve replacement. Am Heart J. 2009;158:540–5.PubMedCrossRefGoogle Scholar
  62. 62.
    Zornoff LAM, Skali H, Pfeffer MA, St John Sutton M, Rouleau JL, Lamas GA, et al. Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction. J Am Coll Cardiol. 2002;39:1450–5.PubMedCrossRefGoogle Scholar
  63. 63.
    Field ME, Solomon SD, Lewis EF, Kramer DB, Baughman KL, Stevenson LW, et al. Right ventricular dysfunction and adverse outcome in patients with advanced heart failure. J Card Fail. 2006;12:616–20.PubMedCrossRefGoogle Scholar
  64. 64.
    D’Alonzo GE, Barst RJ, Ayres AM, Bergofsky EH, Brundage BH, Detre KM, et al. Survival in patients with primary pulmonary hypertension. Ann Intern Med. 1991;115:343–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Klapholz M, Maurer M, Lowe AM, Messineo F, Meisner JS, Mitchell J, et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol. 2004;43:1432–8.PubMedCrossRefGoogle Scholar
  66. 66.
    Tribouilloy C, Rusinaru D, Mahjoub H, Souliere V, Levy F, Peltier M, et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J. 2008;29:339–47.PubMedCrossRefGoogle Scholar
  67. 67.
    Redfield MM, Chen HH, Borlaug BA, Semigran MJ, Lee KL, Lewis G, et al. Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial. JAMA. 2013;309:1268–77.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Division of Cardiovascular MedicineBrigham and Women’s HospitalBostonUSA

Personalised recommendations